Madrigal Pharmaceuticals Inc (NAS:MDGL)
$ 235.06 -7.43 (-3.06%) Market Cap: 5.01 Bil Enterprise Value: 4.23 Bil PE Ratio: 0 PB Ratio: 5.72 GF Score: 42/100

Q1 2024 Madrigal Pharmaceuticals Inc Earnings Call Transcript

May 07, 2024 / 12:00PM GMT
Release Date Price: $217.96 (-7.48%)
Operator

Good day, and thank you for standing by, and welcome to Mattel's Pharmaceuticals First Quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer session. As a reminder, today's conference is being recorded. I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahead.

Tina Ventura
Madrigal Pharmaceuticals Inc - Investor Relations

Thank you, Lisa. Good morning, everyone, and thank you for joining us to discuss Medical's Gold's First Quarter 2024 earnings call. We issued a press release this morning. There is also a supplementary slide deck that accompanies this webcast that will post immediately following the call on the Investor Relations section of our website on the call with me today is Bill Sibold, Chief Executive Officer, and Mardi Dier, Chief Financial Officer, who will provide prepared remarks, and then we'll take your questions.

We're shooting to keep today's call to about 45. Please note, we'll be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot